Long-term outcomes of a phase II study of neoadjuvant imatinib in large gastrointestinal stromal tumors of the stomach

被引:0
作者
Seong-Ho Kong
Yukinori Kurokawa
Jeong-Hwan Yook
Haruhiko Cho
Oh-Kyoung Kwon
Toru Masuzawa
Kyung Hee Lee
Sohei Matsumoto
Young Soo Park
Hiroshi Honda
Seung-Wan Ryu
Takashi Ishikawa
Hye Jin Kang
Kazuhito Nabeshima
Seock-Ah Im
Toshio Shimokawa
Yoon-Koo Kang
Seiichi Hirota
Han-Kwang Yang
Toshirou Nishida
机构
[1] Seoul National University Hospital,Department of Surgery, Cancer Research Institute
[2] Seoul National University College of Medicine Cancer Research Institute,Department of Gastroenterological Surgery
[3] Osaka University Graduate School of Medicine,Department of Surgery
[4] University of Ulsan College of Medicine Asan Medical Center,Department of Surgery
[5] Kanagawa Cancer Center,Department of Surgery
[6] Kyungpook National University School of Medicine,Department of Surgery
[7] Kyungpook National University Chilgok Hospital,Department of Hemato
[8] Osaka Police Hospital,Oncology
[9] Yeungnam University College of Medicine,Department of Surgery
[10] Nara Medical University,Department of Pathology
[11] University of Ulsan College of Medicine Asan Medical Center,Department of Surgery
[12] Sendai Open Hospital,Department of Surgery
[13] Keimyung University Dongsan Hospital,Department of Surgery
[14] Niigata University Graduate School of Medical and Dental Sciences,Department of Internal Medicine, Korea Institute of Radiological & Medical Sciences
[15] Korea Cancer Center Hospital,Department of Surgery
[16] Tokai University,Department of Internal Medicine
[17] Seoul National University Hospital and Seoul National University College of Medicine Cancer Research Institute,Clinical Study Support Center
[18] Wakayama Medical University Hospital,Department of Oncology
[19] University of Ulsan College of Medicine Asan Medical Center,Department of Surgical Pathology
[20] Hyogo Medical University School of Medicine,Department of Surgery
[21] Japan Community Health Care Organization Osaka Hospital,undefined
来源
Gastric Cancer | 2023年 / 26卷
关键词
Gastrointestinal stromal tumor; Imatinib mesylate; Neoadjuvant; Stomach neoplasm;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:775 / 787
页数:12
相关论文
共 125 条
[21]  
Kang YK(2015)Long-term surgical outcome of 1057 gastric GISTs according to 7th UICC/AJCC TNM system: multicenter observational study from Korea and Japan Med (Baltimore) 94 e1526-138
[22]  
Nishida T(2022)Early experience of laparoscopic resection and comparison with open surgery for gastric gastrointestinal stromal tumor: a multicenter retrospective study Sci Rep 12 2290-undefined
[23]  
von Mehren M(2014)Subgroups of patients with very large gastrointestinal stromal tumors with distinct prognoses: a multicenter study J Surg Oncol 109 67-undefined
[24]  
Fletcher CD(2021)Preservation of organ function in locally advanced non-metastatic gastrointestinal stromal tumors (GIST) of the stomach by neoadjuvant imatinib therapy Cancers (Basel) 273 128-undefined
[25]  
Berman JJ(2021)Outcome of 1000 patients with gastrointestinal stromal tumor (GIST) treated by surgery in the pre- and post-imatinib eras Ann Surg undefined undefined-undefined
[26]  
Corless C(undefined)undefined undefined undefined undefined-undefined
[27]  
Gorstein F(undefined)undefined undefined undefined undefined-undefined
[28]  
Lasota J(undefined)undefined undefined undefined undefined-undefined
[29]  
Longley BJ(undefined)undefined undefined undefined undefined-undefined
[30]  
Miettinen M(undefined)undefined undefined undefined undefined-undefined